Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The outcome of patients with metastatic Ewings Sarcoma is poor with current standard of care
chemotherapy, with less than 30% survival. Based on recent encouraging pediatric literature
we have designed this trial to improve the outcome of patients with metastatic Ewings sarcoma
using Irinotecan and Temozolomide in addition to standard chemotherapy.